Page 1 of 1
The Little-Known Genetic Mutation Behind Many Aggressive Cancers
Posted: Thu Dec 13, 2018 3:32 pm
by D.ap
“Despite the dangers of the KRAS-variant mutation, few doctors have heard of it. But one researcher is trying to change that.”
http://discovermagazine.com/2014/dec/16-true-believer
K-ras activation generates an inflammatory response in lung tumors
Posted: Thu Dec 13, 2018 5:21 pm
by D.ap
Activating mutations in K-ras are one of the most common genetic alterations in human lung cancer. To dissect the role of K-ras activation in bronchial epithelial cells during lung tumorigenesis, we created a model of lung adenocarcinoma by generating a conditional mutant mouse with both Clara cell secretory protein (CC10)-Cre recombinase and the Lox-Stop-Lox K-rasG12D alleles. The activation of K-ras mutant allele in CC10 positive cells resulted in a progressive phenotype characterized by cellular atypia, adenoma and ultimately adenocarcinoma. Surprisingly, K-ras activation in the bronchiolar epithelium is associated with a robust inflammatory response characterized by an abundant infiltration of alveolar macrophages and neutrophils. These mice displayed early mortality in the setting of this pulmonary inflammatory response with a median survival of 8 weeks. Bronchoalveolar lavage fluid from these mutant mice contained the MIP-2, KC, MCP-1 and LIX chemokines that increased significantly with age. Cell lines derived from these tumors directly produced MIP-2, LIX and KC. This model demonstrates that K-ras activation in the lung induces the elaboration of inflammatory chemokines and provides an excellent means to further study the complex interactions between inflammatory cells, chemokines and tumor progression.
https://www.nature.com/articles/1209237